About CoviShield

Tribune News Service

Updated At : 12:33 PM Jan 16, 2021 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

India has approved the AstraZeneca and Oxford University-developed vaccine which, in India, is manufactured by the Pune-based Serum Institute of India (the world’s largest manufacturer of the vaccine, by volume). Covishield is the Indian name of the Oxford vaccine. While Bharat Biotech-developed Covaxin is also approved for use in India, in Punjab the Covishield vaccine will be administered during the inoculation drives. The drive would begin after the PM’s interaction with state CMs via videoconference on Saturday morning.

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles